Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 28, 2004Journal of Clinical OncologyOpen Access

Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342

View Full Paper
Ask AI
Bookmark
Share

Authors

EWEric P. WinerDBDonald A. BerrySWSusan Woolf

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Winer et al. (2004) studied this question.

synapsesocial.com/papers/6a74a26696d04a2f43f54bebhttps://doi.org/10.1200/jco.2004.08.048
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quality-of-life assessment: performance status upstaged?1992 · 52 citations
  2. 2Quality of life and survival1998 · 135 citations
  3. 3THE IMPACT OF NATIONAL CANCER ACT1991 · 802 citations
  4. 4Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer2000 · 465 citations
  5. 5Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients With Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-261999 · 155 citations